Dewmar International BMC Inc (OTCMKTS:DEWM) Ready To Breakout

Dewmar International BMC Inc (OTCMKTS:DEWM) has been quiet so far in 2016. The last we heard from the company was the CEO's message on December 31st. However, as of late, shares have been quietly ticking higher. This signals to us that something is brewing and that shares could be out to get on a run.There are number of things the company is working on to drive shares higher. For one, DEWM has hired Malone Bailey to audit its 2014 financials and bring its SEC filing status current. This will go a long way in re-establishing its credibility with the market and proving the naysayers wrong.Second, on the products side, DEWM has a lot going on. DEWM is now selling PhysiPet, Yellow Jacket iPhone Stun Gun/Charger, Rocky Mountain High Hemp , C-Swiss Hemp Iced Tea, Chillo Hemp Energy, Canna Energy, Lean Slow Motion Potion and Kush Cakes through Amazon, Walmart and eBay. DEWM has negotiated new contracts that have allowed DEWM to gain full control of the manufacturing, sales, marketing and brand management rights of several of the aforementioned brands.Third, Lean Slow Motion Protein has completed its third full year on Walmart shelves. DEWM hopes to ramp up its Lean sales by spending a minimum of $100,000 in targeted marketing across social media advertising, radio ads, in-store samplings and brand awareness campaigns.

Get The Inside Scoop On DEWM By Signing Up To Insider Financial Today!

Fourth, DEWM has not heard from the FDA since 2014 regarding labeling of its Lean Slow Motion Protein. According to DEWM:

The main issues the FDA cited involved non-compliant labels; is subsequently being changed to Dietary Supplement Facts labeling. There is no issue with LeanSMP as a Dietary Supplement containing melatonin as an active ingredient.

Fifth, the Kush Cakes line looks very promising. Initial sales to distributors and wholesalers exceeded expectations and created back orders while production ramped up in stages to ensure quality control. DEWM is also looking to develop new products around the Kush Cakes brand. One will include a special new brownie product with an existing client.Lastly, its subsidiary Health & Wellness Research Consortium looks to become a major growth driver for the company. According to Dr. Moran:

The goal of this company is to develop and implement healthcare sales and marketing strategies for pharmacies, clinics and hospitals in order to help maximize the client’s income earning potential. We, in turn, share in the gain in profitability that our team of consultant helped to generate. The Consortium integrates strategic insight, operational excellence and a deep understanding of our specific target market to deliver results by matching a fertile new patient base with pharmacies, clinics and a variety of healthcare specialty care centers.Furthermore, the Consortium invests in healthcare technologies, innovative practices and high profit-margin diagnostic equipment while simultaneously creating value through strategic guidance, operational insights, and industry strategy. We provide our partners and clients with the unique insight to drive critical decision making, improve their performance and achieve sustained profitable growth. As shown in the unaudited 8K financials, the Consortium was responsible for millions of dollars of revenue earnings in 2014. Our upcoming audited financials will show that his revenue trend has been sustained throughout 2015.

We Have A Monster Pick Coming Soon!

Sign Up Today!

We believe Dr. Moran’s goal is to get the stock back to where it was in 2014 when shares hit $.03. Ever since then, DEWM has been stuck in sub penny land. A major overhang on the stock has been its toxic financings that lead to the company having an outstanding share count of 2.4 billion with a free float of 2.2 billion. Dr. Moran is well aware of this issue and addressed this in his annual shareholder letter.

“Dewmar International voided all of its toxic financers by end of March 2014, and in 2015 we kept our promise by not diluting our stock. As this year closes, the number of issued and outstanding shares still remains at 2,426,163,513 while maintaining the same float of 2,225,613,590 shares for the entire year. This is approximately the same number of shares in the float when our stock once was above 3 cents per share. Hopefully, this shows our level of commitment to our investors be more selective about our capital sources and frequency of financing has been the direct result of implemented cost controls and increased revenue.”

Currently trading at a $6.5 million market valuation, DEWM has minimal cash or revenues and growing short term debt. But this is an exciting story developing in sub penny land led by Dr. Marco Moran. We believe the company is working hard behind the scenes as evidenced by the recent 8k and there is general speculation that DEWM is on the cusp of some new developments. We will be updating Insider Financial with the latest developments from DEWM. Be sure to sign up today and stay on top of everything that is happening with DEWM!Disclosure: We have no position in DEWM either long or short. We have not been compensated for this article.